Explore Stanford technologies available for licensing:

Stanford researchers have developed a new methodology called transcript-informed single-cell CRISPR sequencing (TISCC-Seq), for the direct detection and phenotyping of genetic variants in a high-throughput manner.

There are several barriers to widespread use of CAR T-cell therapy. One of them is toxicity, primarily cytokine release syndrome (CRS) and neurologic toxicity, but also on-target off-tumor toxicity.

Stanford scientists have discovered that bispecific antibodies can selectively bind cancer cells and block the CD47-SIRPα "don't eat me signal" to efficiently clear tumors with negligible toxicity.

The DeSimone Research Group at Stanford University developed a method for fabricating 3D pyrolytic carbon structures from polyacrylonitrile (PAN) generated by a scalable Vat Polymerization 3D-printing continuous liquid interface production (CLIP) process.

Researchers at Stanford have developed methods to link antigenic or immunomodulatory molecules to bacterial surface proteins of commensal bacteria that result in a high immune response when applied to an epithelial surface of a mammal.

Researchers at Stanford and UCSF have determined methods of performing cell-free RNA (cfRNA) transcriptomics and metabolomics on urine samples.

Researchers at Stanford have developed an inducible and programmable CRISPR-mediated transcript organization (CRISPR-TO) method for repositioning RNAs to various desired subcellular compartments.

Chronic pain affects millions worldwide, demanding a comprehensive and personalized approach.

Stanford researchers at the Woo Lab have designed and manufactured a flexible, compact laparoscopic device for knot tying during cardiac, thoracic, and ENT operations.

Stanford scientists have discovered that a subset of human cathepsins can degrade cancer-associated mucins.

Stanford researchers have created a system that enables efficient fabrication of complex three-dimensional (3D) nanostructures via triplet-triplet-annihilation upconversion (TTA-UC).

Researchers at Stanford University have developed a method which integrates cell barcoding and high-throughput sequencing to quantify tumor growth in genetically engineered mouse models of human cancer (called 'Tuba-seq” for Tumor barcoding coupled with seq

Researchers at Stanford have proposed that coating surgical sutures with mechanotransduction inhibitors may reduce scarring of the tissue.

Stanford scientists have invented protein degraders that induce lysosomal degradation of extracellular cargo.

Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.